These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25677254)

  • 1. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - The "TRAKT" study.
    Popiel A; Zawadzki B; Pragłowska E; Teichman Y
    J Behav Ther Exp Psychiatry; 2015 Sep; 48():17-26. PubMed ID: 25677254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.
    Schneier FR; Neria Y; Pavlicova M; Hembree E; Suh EJ; Amsel L; Marshall RD
    Am J Psychiatry; 2012 Jan; 169(1):80-8. PubMed ID: 21908494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?
    Cooper AA; Zoellner LA; Roy-Byrne P; Mavissakalian MR; Feeny NC
    J Consult Clin Psychol; 2017 Sep; 85(9):873-882. PubMed ID: 28504542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
    Simon NM; Connor KM; Lang AJ; Rauch S; Krulewicz S; LeBeau RT; Davidson JR; Stein MB; Otto MW; Foa EB; Pollack MH
    J Clin Psychiatry; 2008 Mar; 69(3):400-5. PubMed ID: 18348595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Prolonged Exposure, intensified Prolonged Exposure and STAIR+Prolonged Exposure in patients with PTSD related to childhood abuse: a randomized controlled trial.
    Oprel DAC; Hoeboer CM; Schoorl M; de Kleine RA; Cloitre M; Wigard IG; van Minnen A; van der Does W
    Eur J Psychotraumatol; 2021; 12(1):1851511. PubMed ID: 34630934
    [No Abstract]   [Full Text] [Related]  

  • 6. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
    J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial.
    van den Berg DP; de Bont PA; van der Vleugel BM; de Roos C; de Jongh A; Van Minnen A; van der Gaag M
    JAMA Psychiatry; 2015 Mar; 72(3):259-67. PubMed ID: 25607833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Medications for DSM-5 PTSD in Routine VA Practice.
    Shiner B; Leonard CE; Gui J; Cornelius SL; Schnurr PP; Hoyt JE; Young-Xu Y; Watts BV
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33049805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.
    Oprel DAC; Hoeboer CM; Schoorl M; De Kleine RA; Wigard IG; Cloitre M; Van Minnen A; Van der Does W
    BMC Psychiatry; 2018 Dec; 18(1):385. PubMed ID: 30541492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.
    Rauch SAM; Kim HM; Lederman S; Sullivan G; Acierno R; Tuerk PW; Simon NM; Venners MR; Norman SB; Allard CB; Porter KE; Martis B; Bui E; Baker AW;
    J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34133087
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical Trial.
    Schnurr PP; Chard KM; Ruzek JI; Chow BK; Resick PA; Foa EB; Marx BP; Friedman MJ; Bovin MJ; Caudle KL; Castillo D; Curry KT; Hollifield M; Huang GD; Chee CL; Astin MC; Dickstein B; Renner K; Clancy CP; Collie C; Maieritsch K; Bailey S; Thompson K; Messina M; Franklin L; Lindley S; Kattar K; Luedtke B; Romesser J; McQuaid J; Sylvers P; Varkovitzky R; Davis L; MacVicar D; Shih MC
    JAMA Netw Open; 2022 Jan; 5(1):e2136921. PubMed ID: 35044471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial.
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    J Clin Psychiatry; 2014 Mar; 75(3):222-30. PubMed ID: 24717377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.
    Zandberg LJ; Rosenfield D; Alpert E; McLean CP; Foa EB
    Behav Res Ther; 2016 May; 80():1-9. PubMed ID: 26972745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive prolonged exposure treatment for adolescent complex posttraumatic stress disorder: a single-trial design.
    Hendriks L; de Kleine RA; Heyvaert M; Becker ES; Hendriks GJ; van Minnen A
    J Child Psychol Psychiatry; 2017 Nov; 58(11):1229-1238. PubMed ID: 29057522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.
    Zoellner LA; Telch M; Foa EB; Farach FJ; McLean CP; Gallop R; Bluett EJ; Cobb A; Gonzalez-Lima F
    J Clin Psychiatry; 2017 Jul; 78(7):e782-e789. PubMed ID: 28686823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors.
    Sloan DM; Marx BP; Bovin MJ; Feinstein BA; Gallagher MW
    Behav Res Ther; 2012 Oct; 50(10):627-35. PubMed ID: 22863540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.
    Zoellner LA; Roy-Byrne PP; Mavissakalian M; Feeny NC
    Am J Psychiatry; 2019 Apr; 176(4):287-296. PubMed ID: 30336702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings.
    Duran ÉP; Corchs F; Vianna A; Araújo ÁC; Del Real N; Silva C; Ferreira AP; De Vitto Francez P; Godói C; Silveira H; Matsumoto L; Gebara CM; de Barros Neto TP; Chilvarquer R; de Siqueira LL; Bernik M; Neto FL
    CNS Spectr; 2021 Aug; 26(4):427-434. PubMed ID: 32450928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial.
    Nidich S; Mills PJ; Rainforth M; Heppner P; Schneider RH; Rosenthal NE; Salerno J; Gaylord-King C; Rutledge T
    Lancet Psychiatry; 2018 Dec; 5(12):975-986. PubMed ID: 30449712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.